MedPath

AHLGREN JAMES

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Monoclonal Antibody Therapy and Colony- Stimulating Factor in Treating Patients With Metastatic Colorectal Cancer

Phase 2
Withdrawn
Conditions
Colorectal Cancer
Interventions
Biological: edrecolomab
Biological: sargramostim
First Posted Date
2004-05-24
Last Posted Date
2017-07-13
Lead Sponsor
James Ahlgren
Registration Number
NCT00002664
Locations
🇺🇸

George Washington University Hospital, Washington, D.C., District of Columbia, United States

Vinorelbine Plus Paclitaxel in Treating Patients With Metastatic Prostate Cancer That Is Refractory to Hormone Therapy

Phase 2
Withdrawn
Conditions
Prostate Cancer
Interventions
First Posted Date
2004-05-03
Last Posted Date
2017-07-13
Lead Sponsor
James Ahlgren
Registration Number
NCT00003622
Locations
🇺🇸

George Washington University Hospital, Washington, D.C., District of Columbia, United States

© Copyright 2025. All Rights Reserved by MedPath